UBS analyst Ashwani Verma upgraded Alkermes (NASDAQ: ALKS) from Neutral to Buy with a price target of $42.00 (from $33.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE